Filing Details
- Accession Number:
- 0001127602-13-035383
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-12-20 16:33:01
- Reporting Period:
- 2013-12-18
- Filing Date:
- 2013-12-20
- Accepted Time:
- 2013-12-20 16:33:01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 884731 | Ariad Pharmaceuticals Inc | ARIA | Biological Products, (No Disgnostic Substances) (2836) | 223106987 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1494892 | Frank Haluska | C/O Ariad Pharmaceuticals, Inc. 26 Landsdowne Street Cambridge MA 02139 | Svp, Clinical R&D, Cmo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-12-18 | 12,750 | $0.00 | 96,257 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-12-19 | 5,100 | $5.14 | 91,157 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Footnotes
- Shares were acquired upon vesting of performance stock units awarded on March 20, 2012.
- Represents shares sold to satisfy withholding tax requirements. Shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 20, 2012.
Billionaire Hedge Funds
